 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
outer membrane-bounded periplasmic space
|
1 term
|
 |
|
Biological process
|
antibiotic catabolic process
|
1 term
|
 |
|
Biochemical function
|
hydrolase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Med Chem
47:6556-6568
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
|
|
A.M.Venkatesan,
Y.Gu,
O.Dos Santos,
T.Abe,
A.Agarwal,
Y.Yang,
P.J.Petersen,
W.J.Weiss,
T.S.Mansour,
M.Nukaga,
A.M.Hujer,
R.A.Bonomo,
J.R.Knox.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The design and synthesis of a series of seven tricyclic 6-methylidene penems as
novel class A and C serine beta-lactamase inhibitors is described. These
compounds proved to be very potent inhibitors of the TEM-1 and AmpC
beta-lactamases and less so against the class B metallo-beta-lactamase CcrA. In
combination with piperacillin, their in vitro activities enhanced susceptibility
of all class C resistant strains from various bacteria. Crystallographic
structures of a serine-bound reaction intermediate of 17 with the class A SHV-1
and class C GC1 enzymes have been established to resolutions of 2.0 and 1.4 A,
respectively, and refined to R-factors equal 0.163 and 0.145. In both
beta-lactamases, a seven-membered 1,4-thiazepine ring has formed. The
stereogenic C7 atom in the ring has the R configuration in the SHV-1
intermediate and has both R and S configurations in the GC1 intermediate.
Hydrophobic stacking interactions between the tricyclic C7 substituent and a
tyrosine side chain, rather than electrostatic or hydrogen bonding by the C3
carboxylic acid group, dominate in both complexes. The formation of the 1,4-
thiazepine ring structures is proposed based on a 7-endo-trig cyclization.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Bebrone,
P.Lassaux,
L.Vercheval,
J.S.Sohier,
A.Jehaes,
E.Sauvage,
and
M.Galleni
(2010).
Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
|
| |
Drugs, 70,
651-679.
|
 |
|
|
|
|
 |
G.De Pascale,
and
G.D.Wright
(2010).
Antibiotic resistance by enzyme inactivation: from mechanisms to solutions.
|
| |
Chembiochem, 11,
1325-1334.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev, 23,
160-201.
|
 |
|
|
|
|
 |
P.J.Petersen,
C.H.Jones,
A.M.Venkatesan,
and
P.A.Bradford
(2009).
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.
|
| |
Antimicrob Agents Chemother, 53,
1698-1700.
|
 |
|
|
|
|
 |
P.J.Petersen,
C.H.Jones,
A.M.Venkatesan,
T.S.Mansour,
S.J.Projan,
and
P.A.Bradford
(2009).
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
|
| |
Antimicrob Agents Chemother, 53,
370-384.
|
 |
|
|
|
|
 |
C.R.Bethel,
A.M.Distler,
M.W.Ruszczycky,
M.P.Carey,
P.R.Carey,
A.M.Hujer,
M.Taracila,
M.S.Helfand,
J.M.Thomson,
M.Kalp,
V.E.Anderson,
D.A.Leonard,
K.M.Hujer,
T.Abe,
A.M.Venkatesan,
T.S.Mansour,
and
R.A.Bonomo
(2008).
Inhibition of OXA-1 beta-lactamase by penems.
|
| |
Antimicrob Agents Chemother, 52,
3135-3143.
|
 |
|
|
|
|
 |
M.Kalp,
A.Sheri,
J.D.Buynak,
C.R.Bethel,
R.A.Bonomo,
and
P.R.Carey
(2007).
Efficient inhibition of class A and class D beta-lactamases by Michaelis complexes.
|
| |
J Biol Chem, 282,
21588-21591.
|
 |
|
|
|
|
 |
P.C.Chen,
R.E.Wharton,
P.A.Patel,
and
A.K.Oyelere
(2007).
Direct diazo-transfer reaction on beta-lactam: synthesis and preliminary biological activities of 6-triazolylpenicillanic acids.
|
| |
Bioorg Med Chem, 15,
7288-7300.
|
 |
|
|
|
|
 |
T.C.Terwilliger,
P.D.Adams,
N.W.Moriarty,
and
J.D.Cohn
(2007).
Ligand identification using electron-density map correlations.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
101-107.
|
 |
|
|
|
|
 |
T.S.Mansour,
A.Agarwal,
A.Venkatesan,
T.Abe,
A.Mihira,
T.Takasaki,
K.Sato,
H.Ushirogochi,
I.Yamamura,
T.Isoda,
Z.Li,
Y.Yang,
and
T.Kumagai
(2007).
On the Absolute Configuration in 1,4-Dihydrothiazepine Covalent Complexes Derived from Inhibition of Class A and C beta-Lactamases with 6-Methylidene Penems.
|
| |
ChemMedChem, 2,
1713-1716.
|
 |
|
|
|
|
 |
C.Ma,
H.Ding,
Y.Zhang,
and
M.Bian
(2006).
A ring-expansion methodology involving multicomponent reactions: highly efficient access to polysubstituted furan-fused 1,4-thiazepine derivatives.
|
| |
Angew Chem Int Ed Engl, 45,
7793-7797.
|
 |
|
|
|
|
 |
M.S.Wilke,
A.L.Lovering,
and
N.C.Strynadka
(2005).
Beta-lactam antibiotic resistance: a current structural perspective.
|
| |
Curr Opin Microbiol, 8,
525-533.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|